Medication Safety Governance Structure and Monitoring Process

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jgold@ismp.org. 

6 posts / 0 new
Log in or register to post comments
Last post
Thu, 07/12/2018 - 11:27
#1
audrea Szabatura
audrea Szabatura's picture
Offline
Last seen: 5 years 9 months ago
Joined: 03/20/2015 - 12:47
Medication Safety Governance Structure and Monitoring Process

Hi all,

We have been expanding our services to an increasing number of satellite sites across our state. With this, the ability to oversee the medication use process has become increasingly complex and challenging. We are therefore exploring how to expand our medication safety team. I was wondering if you would mind sharing your medication safety governance structure, including reporting structure (pharmacy versus patient safety department), and whether you oversee other medication safety employees, and what types of committees you use to help prioritize safety initiatives.

Anything you could provide would be greatly appreciated.
Thanks for your help,
Audrea

Audrea H. Szabatura, PharmD, BCOP
Medication Safety Officer
Dana-Farber Cancer Institute
Boston, MA 02215
audreah_szabatura@dfci.harvard.edu

Tags: 

Top